G&L has a wealth of experience in compiling, authoring and publishing regulatory submissions across most markets, as well as liaising with, and submitting to, all major regulatory agencies around the globe.
We have a strong reputation for delivering robust first-time-right regulatory submissions in an agile and timely manner. We support the submission of all types of medicinal products and therapeutic areas, involving small molecules, biologicals, biosimilars, ATMPs, cell therapy and gene therapy. Our comprehensive suite of Publishing and Submission services includes:
eCTD Publishing – all major English-speaking markets (US, EU and ROW)
Other electronic submissions
Submission Management – project and timeline management
Regulatory Data Management
CTD Dossier conversion and preparation of eCTD baselines
Our publishing and submission teams are equally accomplished at utilising either existing client software systems or G&L’s fully- validated, in-house eCTD publishing software suite, Lorenz docuBridge.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.